Upregulation of Bcl-XL, in cooperation with Mcl-1, is a resistance mechanism that has previously been reported for other DLBCL cell models, such as SU-DHL-6, OCI-LY-19 and OCI-LY-1 [33,37]. The gene discussed is MCL1; the disease is diffuse large B-cell lymphoma.